Entity Common Stock, Shares Outstanding of PAVmed Inc. from 06 May 2016 to 20 Mar 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
PAVmed Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 06 May 2016 to 20 Mar 2025.
  • PAVmed Inc. Entity Common Stock, Shares Outstanding for the quarter ending 20 Mar 2025 was 16,787,173, a 80% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

PAVmed Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 16,787,173 +7,468,049 +80% 20 Mar 2025 10-K 24 Mar 2025 2024 FY
Q4 2024 11,523,408 31 Dec 2024 10-K 24 Mar 2025 2024 FY
Q3 2024 10,985,841 -109,774,045 -91% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 10,010,844 -101,407,835 -91% 30 Jun 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 9,319,124 -89,100,671 -91% 31 Mar 2024 10-Q 13 May 2024 2024 Q1
Q3 2023 120,759,886 +27,055,167 +29% 09 Nov 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 111,418,679 +20,419,601 +22% 10 Aug 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 98,419,795 +10,752,389 +12% 09 Mar 2023 10-K 14 Mar 2023 2022 FY
Q3 2022 93,704,719 10 Nov 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 90,999,078 +6,231,485 +7.4% 10 Aug 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 87,667,406 +5,206,686 +6.3% 29 Mar 2022 10-K 06 Apr 2022 2021 FY
Q4 2021 87,930,411 18 Nov 2021 10-Q 22 Nov 2021 2021 Q3
Q2 2021 84,767,593 +37,840,696 +81% 12 Aug 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 82,460,720 +38,326,975 +87% 12 Mar 2021 10-K 15 Mar 2021 2020 FY
Q3 2020 52,254,847 +15,495,719 +42% 04 Nov 2020 10-Q 06 Nov 2020 2020 Q3
Q2 2020 46,926,897 +11,865,748 +34% 26 May 2020 10-Q 28 May 2020 2020 Q1
Q1 2020 44,133,745 +16,240,722 +58% 10 Apr 2020 10-K 14 Apr 2020 2019 FY
Q3 2019 36,759,128 +10,216,149 +38% 12 Nov 2019 10-Q 19 Nov 2019 2019 Q3
Q2 2019 35,061,149 +8,518,170 +32% 12 Aug 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 27,893,023 +10,383,369 +59% 29 Mar 2019 10-K 01 Apr 2019 2018 FY
Q3 2018 26,542,979 +12,667,918 +91% 12 Nov 2018 10-Q 14 Nov 2018 2018 Q3
Q2 2018 26,542,979 +13,211,768 +99% 10 Aug 2018 10-Q 13 Aug 2018 2018 Q2
Q1 2018 17,509,654 +4,178,443 +31% 18 Mar 2018 10-Q 21 May 2018 2018 Q1
Q3 2017 13,875,061 +565,061 +4.2% 10 Nov 2017 10-Q 14 Nov 2017 2017 Q3
Q2 2017 13,331,211 +21,211 +0.16% 11 Aug 2017 10-Q 11 Aug 2017 2017 Q2
Q1 2017 13,331,211 +21,211 +0.16% 12 May 2017 10-Q 22 May 2017 2017 Q1
Q4 2016 13,330,811 10 Feb 2017 10-K 16 Feb 2017 2016 FY
Q3 2016 13,310,000 08 Nov 2016 10-Q 10 Nov 2016 2016 Q3
Q2 2016 13,310,000 12 Aug 2016 10-Q 12 Aug 2016 2016 Q2
Q1 2016 13,310,000 06 May 2016 10-Q/A 20 May 2016 2016 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.